Hongyan Liu

Hongyan Liu

Auto-generated profile, based on publicly available information

Hongyan Liu

Children's Hospital of Philadelphia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2022 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YLYimei Li
Yimei Li
WHWei-Ting Hwang
Wei-Ting Hwang
SMShannon L. Maude
Shannon L. Maude
DTDavid Trent Teachey
David Trent Teachey
NFNoelle V. Frey
Noelle V. Frey
PSPamela A. Shaw
Pamela A. Shaw
Chimeric antigen receptor T-cell (CAR-T) therapy is an exciting development in the field of cancer immunology and has received a lot of interest in recent years. Many time-to-event (TTE) endpoints related to relapse, disease progression, and remission are analyzed in CAR-T studies to assess treatment efficacy. Definitions of these TTE endpoints are not always consistent, even for the same outcomes (e.g., progression-free survival), which often stems from analysis choices regarding which events to consider as part of the composite endpoint, censoring or competing risk in the analysis. Subsequent therapies such as hematopoietic stem cell transplantation are common but are not treated the same in different studies. Standard survival analysis methods are commonly applied to TTE analyses but often without full consideration of the assumptions inherent in the chosen analysis. We highlight two important issues of TTE analysis that arise in CAR-T studies, as well as in other settings in oncology: the handling of competing risks and assessing the association between a time-varying (post-infusion) exposure and the TTE outcome. We review existing analytical methods, including the cumulative incidence function and regression models for analysis of competing risks, and landmark and time-varying covariate analysis for analysis of post-infusion exposures. We clarify the scientific questions that the different analytical approaches address and illustrate how the application of an inappropriate method could lead to different results using data from multiple published CAR-T studies. Codes for implementing these methods in standard statistical software are provided.

28 May 2025 in Blood Cancer Discovery
Verified
Journal Article
Closed access
HNHaley Newman
Haley Newman
SLShawn Lee
Shawn Lee
PPPetri Pölönen
Petri Pölönen
RSRawan Shraim
Rawan Shraim
YLYimei Li
Yimei Li
DTDavid Trent Teachey
David Trent Teachey
The influence of genetic ancestry on genomics in T-cell acute lymphoblastic leukemia (T-ALL) has not been fully explored. We examined the impact of genetic ancestry on multiomic alterations, survival outcomes, and risk stratification. Among 1,309 children and young adults with T-ALL treated on the Children’s Oncology Group trial AALL0434, the prognostic value of five commonly altered T-ALL genes varied by ancestry—including NOTCH1, which was associated with superior overall survival for patients of European ancestry but was nonprognostic among patients of African ancestry. Integrating genetic ancestry with published T-ALL risk classifiers, we identified that an X01 penalized Cox regression classifier stratified patients regardless of ancestry, whereas a European multigene classifier misclassified patients of certain ancestries. Overall, 80% of patients harbored a genomic alteration in at least one gene with differential prognostic impact in an ancestry-specific manner. These data demonstrate the importance of incorporating genetic ancestry into genomic risk classification. Significance: There is a lack of studies examining the prognostic significance of genomic features by genetic ancestry in T-ALL, especially in non-European ancestral groups. In this study, we demonstrate how the prognostic value of individual alterations differs by genetic ancestry, warranting future studies to identify germline alleles affecting these associations. See related commentary by de Smith, p. 400

1 October 2025 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
ADAnushree Doshi
Anushree Doshi
AAAnita Akbar Ali
Anita Akbar Ali
CEChinyere Egbuta
Chinyere Egbuta
TMTessa Mandler
Tessa Mandler
KPKaitlyn Pellegrino
Kaitlyn Pellegrino
CWCourtney Watson
Courtney Watson

3 September 2025
Verified
Other
Open access
HNHaley Newman
Haley Newman
SLShawn Lee
Shawn Lee
PPPetri Pölönen
Petri Pölönen
RSRawan Shraim
Rawan Shraim
YLYimei Li
Yimei Li
DTDavid Trent Teachey
David Trent Teachey
Association of Genetic Ancestries (25% Interval) as Continuous Variables with Biologic Subtype (TAL1 DP-like as reference subtype) Using Multinomial Regression Model.

3 September 2025
Verified
Other
Open access
HNHaley Newman
Haley Newman
SLShawn Lee
Shawn Lee
PPPetri Pölönen
Petri Pölönen
RSRawan Shraim
Rawan Shraim
YLYimei Li
Yimei Li
DTDavid Trent Teachey
David Trent Teachey
Association of NOTCH pathway alteration with Survival Outcomes stratified by categorical genetic ancestry.

3 September 2025
Verified
Other
Open access
HNHaley Newman
Haley Newman
SLShawn Lee
Shawn Lee
PPPetri Pölönen
Petri Pölönen
RSRawan Shraim
Rawan Shraim
YLYimei Li
Yimei Li
DTDavid Trent Teachey
David Trent Teachey
Association of Genetic Ancestry (25% interval) as Continuous Variables with Survival Outcomes.